iDNA Genomics Public (CYS:IDNA) FCF Margin %: 0.00% (As of . 20)


CYS:IDNA iDNA Genomics Public Ltd CYS:IDNA
23 GF Score
Price €22.80
! 2 Warning Signs
View Full Analysis

What is iDNA Genomics Public FCF Margin %?

iDNA Genomics Public CYS:IDNA 23 FCF Margin % is 0.00% as of . 20. GuruFocus rates CYS:IDNA with a GF Score™ of 23/100. The stock has 2 warning signs investors should review.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. iDNA Genomics Public's Free Cash Flow for the six months ended in . 20 was €0.00 Mil. iDNA Genomics Public's Revenue for the six months ended in . 20 was €0.00 Mil. Therefore, iDNA Genomics Public's FCF Margin % for the quarter that ended in . 20 was 0.00%.

As of today, iDNA Genomics Public's current FCF Yield % is 0.00%.

The historical rank and industry rank for iDNA Genomics Public's FCF Margin % or its related term are showing as below:


CYS:IDNA's FCF Margin % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: -1.89
* Ranked among companies with meaningful FCF Margin % only.

iDNA Genomics Public FCF Margin % Related Terms

iDNA Genomics Public FCF Margin % Historical Data

* Premium members only.

The historical data trend for iDNA Genomics Public's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

iDNA Genomics Public FCF Margin % Chart

iDNA Genomics Public Annual Data
Trend
FCF Margin %

iDNA Genomics Public Semi-Annual Data
FCF Margin %

CYS:IDNA vs : FCF Margin % Comparison

For the Diagnostics & Research subindustry, iDNA Genomics Public's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

iDNA Genomics Public FCF Margin % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, iDNA Genomics Public's FCF Margin % distribution charts can be found below:

* The bar in red indicates where iDNA Genomics Public's FCF Margin % falls into.


CYS:IDNA
23GF Score
iDNA Genomics Public Ltd CYS:IDNA
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

iDNA Genomics Public FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

iDNA Genomics Public's FCF Margin for the fiscal year that ended in . 20 is calculated as

FCF Margin=Free Cash Flow (A: . 20 )/Revenue (A: . 20 )
=/
= %

iDNA Genomics Public's FCF Margin for the quarter that ended in . 20 is calculated as

FCF Margin=Free Cash Flow (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
iDNA Genomics Public (CYS:IDNA) has a FCF Margin % of 0.00% as of . 20. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on iDNA Genomics Public and its competitors.
Is iDNA Genomics Public's FCF Margin % too high?
iDNA Genomics Public's current FCF Margin % is 0.00%. Overall, iDNA Genomics Public has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does iDNA Genomics Public's FCF Margin % compare to ?
iDNA Genomics Public's FCF Margin % of 0.00% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Diagnostics & Research company?
A good FCF Margin % depends on the Medical Diagnostics & Research industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on iDNA Genomics Public and its competitors. iDNA Genomics Public's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iDNA Genomics Public stock overvalued right now?
iDNA Genomics Public (CYS:IDNA) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. iDNA Genomics Public's overall GF Score™ is 23/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For iDNA Genomics Public (CYS:IDNA), the current FCF Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

iDNA Genomics Public Business Description

Comparable Companies
Address 7 Hatzidaki Street, Trypiotis, Nicosia, CYP, 1066
iDNA Genomics Public Ltd operates in the field of genomics and biotechnology and specializes in personalized health care. Its purpose is to develop and provide genetic tests in the field of genomics, through professionals (Medical Genomics) and directly to the consumer (Direct-to-Consumer Genomics).
23GF Score

Get the complete analysis for CYS:IDNA

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€22.80
Price